By Richa Naidu LONDON (Reuters) – Reckitt’s Lysol disinfectant brand said on Tuesday that it would start selling in the U.S. an “air sanitizing spray” that kills 99.9% of airborne viruses and bacteria. The spray, which Reckitt said helps reduce the spread of airborne pathogens such as cold, Influenza and Coronavirus, has been approved by…
By Patrick Wingrove (Reuters) – Shawnte struggled with her weight for years before she was prescribed Novo Nordisk’s diabetes drug Ozempic for weight loss in 2020, helping the former music industry professional from New York lose more than 50 pounds over two years. But last year, the 46-year-old, who asked to be identified only by…
By Dietrich Knauth (Reuters) – Johnson & Johnson’s proposed $8.9 billion settlement of thousands of lawsuits alleging that its talc products cause cancer faces a crucial hurdle this week as a U.S. bankruptcy judge in New Jersey considers whether or not a J&J subsidiary may resolve them by filing for bankruptcy a second time. J&J…
By Kevin Yao TIANJIN, China (Reuters) -Chinese Premier Li Qiang on Tuesday said China will take steps to boost demand, invigorate markets, promote development while accelerating the green transition and opening “high level” parts of its economy to the outside world. Addressing a World Economic Forum summit in Tianjin, Li did not elaborate on China’s…
By Ludwig Burger FRANKFURT (Reuters) -Shares in kidney dialysis group Fresenius Medical Care fell as much as 5% on Tuesday after a payment increase proposed by a major U.S. public health insurance body fell short of market expectations. Analysts said the base-rate payment increase of 1.6%, proposed for 2024 by the Centers for Medicare &…
By Brendan Pierson (Reuters) – A California man suing Johnson & Johnson told jurors on Monday how his life was upended by a cancer diagnosis that he blames on using the company’s baby powder since childhood, as the first trial over the product in nearly two years neared its end. “I just turned into a…
(Reuters) -Illumina Inc has commenced job cuts, the genetic sequencing equipment maker said on Monday, as it looks to cushion the impact of sticky inflation and a strong dollar on its business. The company also intends to further cut workforce in the third quarter and reducing its real estate footprint in California as part of…
By Deena Beasley (Reuters) -Eli Lilly on Monday said a mid-stage trial of its next-generation obesity drug candidate “triple G” showed that it led to weight loss of up to 24.2% after 48 weeks, surpassing results seen with other weight loss drugs. The once-weekly injected drug, retatrutide, is part of a class known as incretins…
(Reuters) – Nobel laureate John Goodenough, a pioneer in the development of lithium-ion batteries that today power millions of electric vehicles around the globe, died on Sunday just a month short of his 101st birthday. The American was “was a leader at the cutting edge of scientific research throughout the many decades of his career,”…
(Reuters) -Home health and hospice caregiver Amedisys on Monday agreed to a $3.3 billion sweetened cash offer from UnitedHealth Group and scrapped an all-stock deal with Option Care Health. UnitedHealth is buying the company for $101 per share, which is a dollar higher than its previous offer and above the $97.38 per share all-stock deal…
